Lanreotide acetate
Drug ingredientCAS 127984-74-1
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
10 FDA-registered drug labelers
BCN PEPTIDES SA
Chengdu Shengnuo Biopharm Co., Ltd.
Chunghwa Chemical Synthesis & Biotech. Ltd
Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
Cipla USA Inc.
EXELAN PHARMACEUTICALS, INC.
Ipsen Biopharmaceuticals, Inc.
Qingdao Biopeptek Co., Ltd.
SUN PHARMACEUTICAL INDUSTRIES, INC.
Synergy Health AST, LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Somatuline Depot
- •Lanreotide Acetate
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS127984-74-1
PubChem CID6918010
DTXSIDDTXSID201027706
FormulaC56H73N11O12S2
Mol. Weight1156.4 g/mol
SMILESCC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N.CC(=O)O
Data Sources
- PubChem · compound 6918010Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Lanreotide acetate (CAS 127984-74-1) https://chemicalindependence.com/chemical/127984-74-1/ PubChem: 6918010. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/6918010 FDA National Drug Code directory: CAS 127984-74-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/